MAR 12, 2019 01:53 PM PDT

Tiny Blood Samples Provide Insight Into Newborn Development

WRITTEN BY: Carmen Leitch

After a baby is born, it undergoes a series of rapid biological changes as it develops, adapts to living outside of the womb, and is exposed to microbes in its environment. Researchers don’t know a lot about all of those processes, partly because it’s been challenging to gather large biological samples from newborns, which often are required for extensive studies. Now scientists have found a way to overcome that hurdle; they have developed a technique that uses only half a teaspoon of blood for molecular, metabolic and genetic analysis. The findings have been reported in Nature Communications, and could dramatically improve infant care.

Image credit: Pixabay

"Up to two-thirds of newborn deaths can be prevented if effective health measures are provided at birth and during the first week of life. Of the 5.4 million under-five child deaths per year, about half occur during the neonatal period, i.e., the first month of life,” explained the senior author of the study Beate Kampmann, Professor of Pediatric Infection and Immunity and Director of the Vaccine Center at the London School of Hygiene & Tropical Medicine.

"Knowledge about key developmental processes during our earliest days remains sparse, but this study plugs some of those crucial gaps. This work is particularly important for vaccine research. Newborns have very limited protection from infection in early life and there is an urgent need to optimize protective measures, including vaccines, used in this age group,” added Kampmann.

For this work, scientists involved with the Expanded Program on Immunization Consortium (EPIC), including researchers at the MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine, used computational approaches to integrate data obtained from the samples they collected. Unsurprisingly, they revealed thousands of changes in immunity and gene expression. 

In this study, the parents of newborns living in communities of The Gambia in West Africa were recruited. Two blood samples were taken from the infants - one when they were born, and one on either the first, third, or seventh day of life.

After processing, the researchers revealed dramatic biochemical changes as development proceeded. Their work was then confirmed in another group of newborns in Australia. There were common trajectories in the development of the two groups, indicating that age-specific biological pathways are at work.

"The MRC Unit in The Gambia has carried out important studies in newborns for a long time in order to optimize the use of vaccines. Given our excellent community relations and infrastructure, we were ready to partner with our collaborators to apply the new tools of systems biology to very small blood samples. We wanted to establish this work in a real-world situation in order to gain insight into immune development in a setting where new interventions can have the biggest impact on newborn survival,” said Kampmann.

"Most infections in the world occur early in life, and newborns have the greatest susceptibility and the worst outcomes. This work provides a valuable window into health and disease in the first week of life. Our exciting findings allows us to ask bigger questions about the differences between different populations and the impact of biomedical interventions such as vaccines on development,” said a senior author of the work Ofer Levy, Director of the Precision Vaccines Program at Boston Children's Hospital.

"Currently, most vaccines are developed by trial and error. We seek deep molecular insight into vaccine function in early life so we can better develop infant vaccines for the future. We demonstrated that it's possible to recruit newborns in a resource-poor setting, obtain small amounts of their blood, process it, ship it, conduct systems biology assays and integrate the results -- turning big data into knowledge."

Larger batches of patient samples will be needed to confirm these findings, and the authors are already looking at the impact of vaccines in a follow-up project in The Gambia and Papua New Guinea. More participants will be included in that work.

Professor Kampmann is featured discussing her research in the video.

 


Sources: AAAS/Eurekalert! via London School of Hygiene & Tropical Medicine, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 05, 2019
Cell & Molecular Biology
JAN 05, 2019
The Body's Largest Cellular Receptor is Identified
The structure of a huge receptor in the body, which binds to vitamin B12, has now been elucidated....
JAN 06, 2019
Cell & Molecular Biology
JAN 06, 2019
An Inhalable Form of Messenger RNA Might be a New Kind of Therapeutic
Messenger RNA normally carries genetic information from the genome to the ribosome, but researchers want to use it to treat disease....
JAN 16, 2019
Genetics & Genomics
JAN 16, 2019
Gene Therapy for a Leading Cause of Infant Death is Closer to Market
New treatments for some diseases can have extremely high price tags. One example is Zolgensma, which might cost $5 million per patient....
JAN 29, 2019
Genetics & Genomics
JAN 29, 2019
Heavy Drinking may Have a Lasting Epigenetic Effect
Researchers have found that alcohol may be exerting an epigenetic effect on heavy or binge drinkers....
FEB 03, 2019
Genetics & Genomics
FEB 03, 2019
The Effort to Sequence the Genomes of 1.5 Million Species
The Earth BioGenome Project aims to sequence and characterize the genomes of all known eukaryotes....
FEB 20, 2019
Genetics & Genomics
FEB 20, 2019
Scientists Learn How a Common Bacterium Turns Deadly
Strep throat is a common illness. Now researchers know why it sometimes causes a flesh-eating disease....
Loading Comments...